The Prosthetic Joint Infection Market will grow at highest pace owing to rising geriatric population

Prosthetic joint infections occur when bacteria or other microorganisms infect a joint replaced by an artificial joint such as a hip, knee, shoulder, or elbow prosthesis. Prosthetic joint infection disrupts the attachment between the implant and bone, causing pain, swelling, and loss of mobility. If untreated, prosthetic joint infection can lead to severe bone and tissue destruction. Risk factors for prosthetic joint infection include previous joint infection, diabetes, rheumatoid arthritis, and obesity. Treatment involves prolonged intravenous and oral antibiotic therapy along with surgical debridement to remove infected tissues.

The prosthetic joint infection market is estimated to be valued at USD 64.2 Mn in 2024 and is expected to reach USD 91.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

Key players operating in the prosthetic joint infection market are Stryker Corporation, Zimmer Biomet, Smith & Nephew, and CONMED Corporation.

Growing geriatric population worldwide is increasing the demand Prosthetic Joint Infection Market which is expected to drive the growth of the prosthetic joint infection market. According to the United Nations, the population aged 60 years and above is projected to double from 12% to 22% from 2015 to 2050 globally and the aging population is more prone to prosthetic joint infections.

Technological advancements in prosthetic joint infection treatment such as drug-coated implants and personalized antibiotic therapy are expected to boost market growth. 3D printing technology is being utilized to design patient-specific implants coated with antibiotics which ensures targeted drug delivery at the infection site.

Market TrendsGrowing popularity of outpatient joint replacement surgeries: To reduce healthcare costs, there is an increasing trend of performing elective joint replacement surgeries in outpatient settings. However, outpatient joints surgery patients are at higher risk of prosthetic joint infections due to early discharge from hospitals.Increasing adoption of single-stage surgical debridement: Previously, two-stage surgical debridement involving implant removal followed by reimplantation after a few months was the standard treatment approach for prosthetic joint infections. However, single-stage surgical debridement along with prolonged antibiotics therapy is gaining acceptance due to its advantages like fewer additional surgeries and lower costs.

Market Opportunities Development of novel biofilm-disrupting biomaterials: Bacteria grow as biofilm on implant surfaces making them highly resistant to antibiotics. Developing biomaterials that disrupt bacterial biofilm formation can help prevent implant-associated chronic infections.Rising demand in developing countries: With rapid economic growth and expanding middle-class populations, the joint replacement volume in countries like India, China, and Brazil is growing significantly. This presents an opportunity for prosthetic joint infection treatment market players to establish their presence in emerging markets.

Impact of COVID-19 on Prosthetic Joint Infection Market Growth The COVID-19 pandemic negatively impacted the prosthetic joint infection market in the initial period. During the lockdowns imposed across various countries, elective surgeries were postponed or canceled to avoid straining the healthcare infrastructure and minimize virus transmission risk. This led to a substantial decline in the number of joint replacement procedures performed globally. As per estimates, the volume reduction was over 30-40% during the peak months of the pandemic.The supply chain disruptions caused by transport restrictions further compounded the situation by delaying the procurement of essential materials and devices. Moreover, hospitals prioritized COVID-19 care and reallocated resources like surgical beds, diverting attention from elective orthopedic services. However, as lockdowns eased and vaccination drives progressed worldwide, surgical volumes started picking up gradually. Many countries witnessed over 80-90% recovery in joint replacement volumes by late 2021 and early 2022 compared to pre-pandemic levels.The geographical concentration of value in the prosthetic joint infection market has been highest in North America. Countries like the US and Canada have accounted for around 40% share due to the high frequency of hip and knee replacement surgeries in the region. However, Asia Pacific region is poised to be the fastest-growing market during the forecast period. This is attributed to factors like the rising geriatric population, improving access to healthcare, and increasing focus of leading medical device companies on tapping opportunities in Asian countries.

Asia Pacific Region Fastest Growing for Prosthetic Joint Infection MarketThe Asia Pacific region is expected to witness the fastest growth in the prosthetic joint infection market between 2024-2031. Some of the key factors contributing to the growth include -- Rapidly aging populations in China and India result in a growing patient pool requiring joint replacement procedures. As life expectancy increases in Asia, age-related joint disorders will rise accordingly.- Expanding medical tourism industries in countries like Thailand, Singapore and India are attracting more international patients for knee and hip replacement surgeries. This will naturally drive up the post-surgery infection treatment need.- Developing healthcare infrastructure and increasing healthcare expenditures are enhancing the availability of advanced orthopedic care across Asia. This augurs well for managing prosthetic joint complications.- Major global medical device companies have been expanding their R&D investments and manufacturing footprints in Asia to take advantage of the emerging opportunities. Their presence is improving access to high-quality prosthetic joint infection treatment options.- Favorable government policies supporting privatization of healthcare and medical insurance schemes are helping more patients opt for elective surgeries without financial barriers. This favors market growth.The above factors are expected to propel the Asia Pacific region to a CAGR exceeding 7% during the forecast period, surpassing other geographic markets for prosthetic joint infection treatment.

Get more insights on – Prosthetic Joint Infection Market

Get this Report in Japanese Language:  人工関節感染症市場

Get this Report in Korean Language: 인공 관절 감염 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)